Back to News
Market Impact: 0.3
ACB's Q2 Earnings on Deck: International Medical Cannabis in Focus
Source: zacks.com
Corporate EarningsAnalyst EstimatesCompany FundamentalsHealthcare & Biotech
Aurora Cannabis heads into Q2 earnings with revenue expected to decline 20.1%. Market exits and reimbursement cuts are weighing on results, partly offset by support from international medical cannabis markets.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.30
Ticker Sentiment
ACB-0.50
More News
- SK Hynix Posts Record Profit Amid AI Rush
- SK Hynix third-quarter profit sharply beats estimates on AI memory boost
- Anthropic's IPO could be 'speculative fiction' or a 'generational moment' — investors are split
- Tech's relief rally extends as attention turns to tough decisions for the Fed
- Anthropic Gives Traders a Pure-Play Bet on Frontier AI
- Analysis-Hold or sell? High Treasury yields spur US banks to rethink bond portfolios